IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $5,098,000 | +389.3% | 211,520 | +22.4% | 0.00% | +300.0% |
Q1 2014 | $1,042,000 | -4.0% | 172,820 | -4.8% | 0.00% | 0.0% |
Q4 2013 | $1,085,000 | +15.8% | 181,520 | +0.9% | 0.00% | 0.0% |
Q3 2013 | $937,000 | +47.6% | 179,869 | +2.3% | 0.00% | 0.0% |
Q2 2013 | $635,000 | – | 175,791 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 29,665,693 | $153,965,000 | 4.40% |
Bain Capital Public Equity Management, LLC | 12,664,950 | $65,731,000 | 1.65% |
BRIDGER MANAGEMENT, LLC | 4,360,628 | $22,632,000 | 1.62% |
12 West Capital Management LP | 1,782,100 | $9,249,000 | 1.32% |
GENERAL AMERICAN INVESTORS CO INC | 858,979 | $4,458,000 | 0.39% |
BB BIOTECH AG | 1,250,000 | $6,488,000 | 0.35% |
Aris Wealth Services, Inc. | 30,000 | $156,000 | 0.28% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 800,400 | $4,154,000 | 0.16% |
Visium Asset Management, LP | 1,307,132 | $6,810,000 | 0.15% |
Old West Investment Management, LLC | 59,038 | $306,000 | 0.15% |